Pfizer Q2 FY25: where the revenue came from and where it went
The whole income statement of Pfizer for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Mar 31 – Jun 29, 2025
- Reported
- Aug 5, 2025
Revenue$14.7B
+10% year over year
Gross profit$10.9B
74% margin
Operating profit−$3.1B
−21% margin
Net profit$2.9B
20% margin
Net profit is larger than what operations earned, because the statement adds $6.1B below it, under Other income, net.
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 14.7 | 100% | +10% |
| US | 8.9 | 61% | +13% |
| Developed markets | 3.4 | 23% | +7% |
| International emerging | 2.4 | 16% | +6% |
| Cost of revenue | −3.8 | 26% | |
| Gross profit | 10.9 | 74% margin | −1pp |
| SG&A | −3.4 | 23% | −5pp |
| Other | −10.5 | 72% | +0pp |
| Operating profit | −3.1 | −21% margin | +0pp |
| Other income, net | 6.1 | ||
| Tax | −0.1 | ||
| Net profit | 2.9 | 20% margin | +20pp |
359 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest